Terbutaline Export Market Intelligence: India's 98 Suppliers Shipping to 59 Countries — TransData Nexus 2026

Q: Who are the top terbutaline exporters from India?

The top terbutaline exporters from India are: 1. UMAVIDA PHARMA PRIVATE LIMITED — $2.2M (63.5% market share); 2. MCW HEALTHCARE PRIVATE LIMITED — $154.0K (4.4% market share); 3. CROIENT PHARMA PRIVATE LIMITED — $113.0K (3.2% market share); 4. ZYDUS LIFESCIENCES LIMITED — $104.9K (3.0% market share); 5. AHAAN HEALTHCARE PRIVATE LIMITED — $95.3K (2.7% market share). Together they account for 76.9% of India's total terbutaline export value.

Q: What is the total export value of terbutaline from India?

The total export value of terbutaline from India is $3.5M USD, recorded across 297 shipment transactions from 98 active exporters to 59 destination countries. The average shipment value is $11.7K.

Q: Which countries import terbutaline from India?

India exports terbutaline to 59 countries worldwide. The top importing countries are: ANGOLA (63.5% share, $2.2M), SRI LANKA (7.2% share, $251.9K), FRANCE (6.2% share, $216.9K), KENYA (3.9% share, $135.1K), JAMAICA (2.9% share, $101.1K). These five markets account for 83.8% of total export value.

Q: What is the HS code for terbutaline exports from India?

The primary HS code for terbutaline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of terbutaline exports from India?

The average unit price for terbutaline exports from India is $2.90 USD per unit, with prices ranging from $0.05 to $262.29 depending on formulation, packaging, and order volume. The total market is valued at $3.5M across 297 shipments.

Q: Which ports handle terbutaline exports from India?

The primary ports for terbutaline exports from India are NHAVA SHEVA SEA (INNSA1) (15.2% of shipments), JNPT (12.1% of shipments), JNPT/ NHAVA SHEVA SEA (10.4% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.1% of shipments), Bombay Air (6.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of terbutaline?

India is one of the world's leading exporters of terbutaline due to its large base of 98 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports terbutaline to 59 countries, demonstrating 30% global market coverage.

Q: What certifications do Indian terbutaline exporters need?

Indian terbutaline exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import terbutaline from India?

There are 131 registered buyers importing terbutaline from India, spread across 59 countries. The repeat buyer rate is 46.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top terbutaline supplier from India?

UMAVIDA PHARMA PRIVATE LIMITED is the leading terbutaline exporter from India with a market share of 63.5% and total export value of $2.2M across 8 shipments. The top 5 suppliers together control 76.9% of total export value.

Suresh Sormare

Terbutaline

India Pharmaceutical Trade Intelligence

$3.5M98 Suppliers59 CountriesHS 30049099

ExportsIndia → ANGOLA63.5%India → SRI LANKA7.2%

#1 Supplier: UMAVIDA PHARMA #1 Buyer: PRINCE FARMA,

Terbutaline Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Terbutaline to the World

Between 2022 and 2026, India exported $3.5M worth of terbutaline across 297 verified shipments to 59 countries — covering 30% of world markets in the Respiratory & OTC segment. The largest destination is ANGOLA (63.5%). UMAVIDA PHARMA PRIVATE LIMITED leads with a 63.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Terbutaline export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Terbutaline export data snapshot — $3.5M · 98 exporters · 59 countriesTransData Nexus · Indian Customs Data

Top Terbutaline Exporters from India

98 active exporters · Ranked by export value

View all 98 →

Top Terbutaline Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	UMAVIDA PHARMA PRIVATE LIMITED	$2.2M	8	1	63.5%
2	MCW HEALTHCARE PRIVATE LIMITED

Top Countries Importing Terbutaline from India

59 destination markets · Ranked by import value

All 59 countries →

Top Countries Importing Terbutaline from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	ANGOLA	$2.2M	63.5%
2	SRI LANKA	$251.9K	7.2%
3	FRANCE	$216.9K	6.2%
4	KENYA	$135.1K	3.9%
5	JAMAICA	$101.1K	2.9%
6	MAURITIUS	$70.5K	2.0%
7	CAMBODIA	$58.6K	1.7%
8	MALAWI	$47.9K	1.4%
9	YEMEN	$42.9K	1.2%
10	AZERBAIJAN	$40.7K	1.2%

ANGOLA is India's largest terbutaline export destination, absorbing 63.5% of total exports worth $2.2M. The top 5 importing countries — ANGOLA, SRI LANKA, FRANCE, KENYA, JAMAICA — together account for 83.8% of India's total terbutaline export value. The remaining 54 destination countries collectively receive the other 16.2%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Terbutaline

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, terbutaline is approved for the treatment of bronchospasm associated with asthma, bronchitis, and emphysema. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for terbutaline sulfate tablets and injections, indicating a well-established generic market. As of March 2026, there are no active import alerts related to terbutaline, suggesting compliance with FDA standards among exporters. However, in February 2011, the FDA issued a Drug Safety Communication warning against the use of terbutaline for prolonged treatment of preterm labor due to potential serious maternal heart problems and death. This led to the addition of a Boxed Warning and Contraindication to the terbutaline injection label.

Given the competitive landscape, Indian exporters must ensure strict adherence to FDA regulations, including Good Manufacturing Practices (GMP) and accurate labeling, to maintain and expand their market share in the U.S.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, terbutaline is authorized for the treatment of asthma and other respiratory conditions. The European Medicines Agency (EMA) has conducted periodic safety assessments of terbutaline. In October 2022, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updates to the product information to emphasize the risks associated with overuse, including deteriorating asthma control and life-threatening exacerbations. (ema.europa.eu)

Additionally, in October 2013, the EMA restricted the use of short-acting beta-agonists, including terbutaline, for obstetric indications due to safety concerns. (ema.europa.eu) Compliance with EU GMP requirements is mandatory for market authorization, necessitating that Indian exporters align their manufacturing processes with these standards to ensure continued access to these markets.

3WHO Essential Medicines & Global Standards

Terbutaline is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, underscoring its importance in global health. (who.int) The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, terbutaline is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for terbutaline formulations to ensure affordability; however, the exact ceiling price and date of implementation should be verified from the latest NPPA notifications. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Terbutaline's primary patents have expired, leading to a robust generic market with multiple manufacturers producing the drug. This competitive environment necessitates that Indian exporters focus on maintaining high-quality standards and cost-effective production to remain competitive in both domestic and international markets.

6Recent Industry Developments

In October 2022, the EMA's PRAC recommended updates to terbutaline product information to highlight the risks associated with overuse, including deteriorating asthma control and life-threatening exacerbations. (ema.europa.eu)

In September 2025, the WHO published the 24th edition of its Model List of Essential Medicines, reaffirming terbutaline's status as an essential medicine for respiratory conditions. (who.int)

These developments underscore the importance of continuous monitoring of regulatory changes and adherence to international standards to ensure market access and patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Terbutaline

Retail & reference prices across 9 markets vs. India FOB export price of $2.90/unit

Global Price Benchmark for Terbutaline across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA Orange Book, Terbutaline is an approved medication in the U.S.
United Kingdom	Data not available	GBP	As of September 2025, the UK's Department of Health and Social Care implemented an export ban on Terbutaline, indicating potential supply constraints.
Germany	Data not available	EUR	Terbutaline is listed in the European Medicines Agency (EMA) database, indicating its approval for use in Germany.
Australia	Data not available

Supply Chain Risk Assessment — Terbutaline

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Terbutaline, a bronchodilator used in the treatment of asthma and bronchospasm, relies on Active Pharmaceutical Ingredients (APIs) that are predominantly manufactured in India. However, the production of these APIs is heavily dependent on Key Starting Materials (KSMs) sourced from China. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting a significant supply chain vulnerability.

This dependency has been exposed during instances where Chinese regulatory actions led to the shutdown of API manufacturers failing to meet pollution norms, causing supply disruptions and cost escalations. Such events underscore the risks associated with over-reliance on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Terbutaline from India account for 76.9% of the total export value, with UMAVIDA PHARMA PRIVATE LIMITED alone contributing 63.5%. This high supplier concentration poses a significant risk, as any disruption affecting these key players could severely impact global supply chains.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing import dependence on critical pharmaceutical ingredients. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a step towards self-reliance.

Access Complete Terbutaline Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 297 transactions across 59 markets.

Request Demo View Pricing

Frequently Asked Questions — Terbutaline Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top terbutaline exporters from India?

The leading terbutaline exporters from India are UMAVIDA PHARMA PRIVATE LIMITED, MCW HEALTHCARE PRIVATE LIMITED, CROIENT PHARMA PRIVATE LIMITED, and 8 others. UMAVIDA PHARMA PRIVATE LIMITED leads with 63.5% market share ($2.2M). The top 5 suppliers together control 76.9% of total export value.

What is the total export value of terbutaline from India?

The total export value of terbutaline from India is $3.5M, recorded across 297 shipments from 98 active exporters to 59 countries. The average shipment value is $11.7K.

Which countries import terbutaline from India?

India exports terbutaline to 59 countries. The top importing countries are ANGOLA (63.5%), SRI LANKA (7.2%), FRANCE (6.2%), KENYA (3.9%), JAMAICA (2.9%), which together account for 83.8% of total export value.

What is the HS code for terbutaline exports from India?

The primary HS code for terbutaline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Terbutaline

Terbutaline

How India Exports Terbutaline to the World

Top Terbutaline Exporters from India

Top Countries Importing Terbutaline from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Regulatory Landscape — Terbutaline

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Terbutaline

Supply Chain Risk Assessment — Terbutaline

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Terbutaline Trade Intelligence

Frequently Asked Questions — Terbutaline Exports from India

Who are the top terbutaline exporters from India?

What is the total export value of terbutaline from India?

Which countries import terbutaline from India?

What is the HS code for terbutaline exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of terbutaline exports from India?

Which ports handle terbutaline exports from India?

Why is India a leading exporter of terbutaline?

What certifications do Indian terbutaline exporters need?

How many buyers import terbutaline from India?

What is the market share of the top terbutaline exporter from India?

Analysis Methodology